Small Airways Disease (SAD): Asthma and COPD
Small airways disease is present across all stages of asthma and COPD1,2 and an estimated 90% of patients with asthma and symptomatic COPD have small airways disease (SAD)3,4.
Consultant Respiratory Nurse Emma Rickards talks about the consequences of small airways disease in COPD with reference to early identification, airway obstruction, gas trapping and exacerbation risk.
She then considers the consequences of SAD for individuals with asthma – and how to consider it in clinical practice and within primary care. Nurse Rickards discusses the SADT (Small Airways Dysfunction tool), clinical clues which may help diagnosis and suitable management approaches.
Please also consider watching the on-demand video ‘The Importance of the Small Airways in Asthma and COPD‘ by Dr Rory Chan who presents on the pathophysiology, prevalence, severity and assessment of SAD in respiratory patients.
References
In a prospective cohort study of patients with asthma (N=773) and an observational study of patients with COPD (N=202); symptomatic COPD defined as CAT score ≥10.1,2
1. Toumpanakis D, Usmani OS. Chin Med J Pulm Crit Care Med. 2023; 1(3): 171–180.
2. Rath AK, et al. Tuberc Respir Dis (Seoul). 2024; 87(2): 165–175
3. Postma DS, et al. Lancet Respir Med. 2019; 7(5): 402–416
4. Crisafulli E, et al. Respiration. 2017; 93: 32–41
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
-
Read biography
Emma Rickards
Respiratory Nurse Consultant